AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteBromfenac sodium is a topically selective cyclooxygenase (COX)-2 inhibitor
More Information Supplier PageBromfenac sodium is a topically selective cyclooxygenase (COX)-2 inhibitor
More Information Supplier PageBromocriptine mesylate is a potent dopamine receptor agonist that binds the D2 receptor with highest affinity (Ki = 2.5 nM).1,2 As a result, it has found applications in combination therapy for Parkinsonism.
More Information Supplier PageBromocriptine mesylate is a potent dopamine receptor agonist that binds the D2 receptor with highest affinity (Ki = 2.5 nM).1,2 As a result, it has found applications in combination therapy for Parkinsonism.
More Information Supplier PageBromosporine is a broad spectrum inhibitor for bromodomains with IC50 of 0.41 ??M, 0.29 ??M, 0.122 ??M and 0.017 ??M for BRD2, BRD4, BRD9 and CECR2, respectively.
More Information Supplier PageBromosporine is a broad spectrum inhibitor for bromodomains with IC50 of 0.41 ??M, 0.29 ??M, 0.122 ??M and 0.017 ??M for BRD2, BRD4, BRD9 and CECR2, respectively.
More Information Supplier PageBromosporine is a broad spectrum inhibitor for bromodomains with IC50 of 0.41 ??M, 0.29 ??M, 0.122 ??M and 0.017 ??M for BRD2, BRD4, BRD9 and CECR2, respectively.
More Information Supplier PageBromosporine is a broad spectrum inhibitor for bromodomains with IC50 of 0.41 ??M, 0.29 ??M, 0.122 ??M and 0.017 ??M for BRD2, BRD4, BRD9 and CECR2, respectively.
More Information Supplier PageBrompheniramine is a first-generation antihistamine. Brompheniramine works by acting as an antagonist of histamine H1 receptors. It also functions as a moderately effective anticholinergic agent, and is likely an antimuscarinic agent similar to other common antihistamines such as diphenhydramine.
More Information Supplier PageBroussonetine A was extracted from Broussonetia papyrifera dried leaves .
More Information Supplier PageBroussonetine A was extracted from Broussonetia papyrifera dried leaves .
More Information Supplier PageBroussonetine A was extracted from Broussonetia papyrifera dried leaves .
More Information Supplier PageBryostatin 1 is a macrolactone isolated from the marine bryozoan, Bugula neritina, that modulates protein kinase C (PKC) activity. Bryostain 1 induces an initial rapid activation and autophosphorylation of PKC that results in the translocation of the PKC enzyme to the membrane.
More Information Supplier PageBSI-201 is a potent inhibitor of PARP-1 and has been shown to cross the blood-brain barrier.
More Information Supplier PageBSI-201 is a potent inhibitor of PARP-1 and has been shown to cross the blood-brain barrier.
More Information Supplier PageBSI-201 is a potent inhibitor of PARP-1 and has been shown to cross the blood-brain barrier.
More Information Supplier PageBSI-201 is a potent inhibitor of PARP-1 and has been shown to cross the blood-brain barrier.
More Information Supplier PageBSI-201 is a potent inhibitor of PARP-1 and has been shown to cross the blood-brain barrier.
More Information Supplier PageBTB06584 is an IF1-dependent, selective inhibitor of the mitochondrial F1 Fo-ATPase.
More Information Supplier PageBTB06584 is an IF1-dependent, selective inhibitor of the mitochondrial F1 Fo-ATPase.
More Information Supplier PageBTB06584 is an IF1-dependent, selective inhibitor of the mitochondrial F1 Fo-ATPase.
More Information Supplier PageBTB06584 is an IF1-dependent, selective inhibitor of the mitochondrial F1 Fo-ATPase.
More Information Supplier PageBTZ043 (BTZ038, BTZ044) inhibits decaprenylphosphoryl-??-d-ribose 2?-epimerase, which is an enzyme which produces the cell wall of the pathogenic bacterium Mycobacterium tuberculosis.
More Information Supplier PageBTZ043 (BTZ038, BTZ044) inhibits decaprenylphosphoryl-??-d-ribose 2?-epimerase, which is an enzyme which produces the cell wall of the pathogenic bacterium Mycobacterium tuberculosis.
More Information Supplier PageBTZ043 (BTZ038, BTZ044) inhibits decaprenylphosphoryl-??-d-ribose 2?-epimerase, which is an enzyme which produces the cell wall of the pathogenic bacterium Mycobacterium tuberculosis.
More Information Supplier PageBTZ043 (BTZ038, BTZ044) inhibits decaprenylphosphoryl-??-d-ribose 2?-epimerase, which is an enzyme which produces the cell wall of the pathogenic bacterium Mycobacterium tuberculosis.
More Information Supplier PageBTZ043 (BTZ038, BTZ044) inhibits decaprenylphosphoryl-??-d-ribose 2?-epimerase, which is an enzyme which produces the cell wall of the pathogenic bacterium Mycobacterium tuberculosis.
More Information Supplier PageBudesonide is a glucocorticoid steroid for the treatment of asthma, non-infectious rhinitis.
More Information Supplier PageBudesonide is a glucocorticoid steroid for the treatment of asthma, non-infectious rhinitis.
More Information Supplier PageBudesonide is a glucocorticoid steroid for the treatment of asthma, non-infectious rhinitis.
More Information Supplier PageBudesonide is a glucocorticoid steroid for the treatment of asthma, non-infectious rhinitis.
More Information Supplier PageBudesonide is a glucocorticoid steroid for the treatment of asthma, non-infectious rhinitis.
More Information Supplier PageBufalin is a cardiotonic steroid originally isolated from the Chinese toad venom.
More Information Supplier PageBufalin is a cardiotonic steroid originally isolated from the Chinese toad venom.
More Information Supplier PageBufalin is a cardiotonic steroid originally isolated from the Chinese toad venom.
More Information Supplier PageBufalin is a cardiotonic steroid originally isolated from the Chinese toad venom.
More Information Supplier PageBuflomedil is a vasoactive agent used to treat peripheral vascular disease.
More Information Supplier PageBuflomedil is a vasoactive agent used to treat peripheral vascular disease.
More Information Supplier PageBuflomedil is a vasoactive agent used to treat peripheral vascular disease.
More Information Supplier PageBufotalin is a less potent Na+/K+-ATPase inhibitor than other bufadienolides. Potent immunosuppressor.
More Information Supplier PageBufotalin is a less potent Na+/K+-ATPase inhibitor than other bufadienolides. Potent immunosuppressor.
More Information Supplier PageBufotalin is a less potent Na+/K+-ATPase inhibitor than other bufadienolides. Potent immunosuppressor.
More Information Supplier PageBufotalin is a less potent Na+/K+-ATPase inhibitor than other bufadienolides. Potent immunosuppressor.
More Information Supplier Page
